Q2 2024 Hyperfine Inc Earnings Call Transcript
Key Points
- Hyperfine Inc (HYPR) reported a record revenue of $3.6 million for Q2 2024, marking a 7% increase compared to Q2 2023.
- The company achieved a record gross margin of 50% in Q2 2024, up from previous quarters.
- FDA clearance of the ninth generation AI-powered software enhances imaging capabilities, improving clinical performance.
- Strong international revenue contributions and a growing pipeline of flagship accounts in the US.
- Significant progress in clinical programs, including Alzheimer's and stroke studies, with promising initial data presented at major conferences.
- Net loss for Q2 2024 was $10.1 million, only a slight improvement from the $10.6 million loss in Q2 2023.
- R&D expenses increased to $5.9 million in Q2 2024 from $5.3 million in Q2 2023, indicating higher operational costs.
- The company anticipates some summer seasonality impact on revenue due to increased international revenue mix.
- Cash burn for Q2 2024 was $9.4 million, with a total expected cash burn of approximately $40 million for the full year 2024.
- Despite positive developments, the commercial entry into Alzheimer's care is not expected to contribute to revenue until the second half of 2025.
Good afternoon and welcome to Hyperfine's second quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Marissa Bych from Gilmartin Group for introductory disclosures.
Thank you for joining today's call. Earlier today, Hyperfine Inc. released financial results for the quarter ended June 30, 2024. A copy of the press release is available on the company's website as well as sec.gov.
Before we begin, I'd like to remind you that management may make statements during this call include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including without limitation, those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
